NEW YORK (GenomeWeb News) – Strand Life Sciences today said that financial services firm Burrill & Co. has invested in the firm's Series B round of financing.

The amount of Burrill's investment is not being disclosed by the Bangalore, India-based bioinformatics firm. However, Strand noted that the financing included both a primary investment into the firm and a secondary buy-out of the lead investors from its Series A round.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.